Treatment of advanced-stage hodgkin lymphoma: let us face the facts

Comment

Peter Borchmann et al. J Clin Oncol. 2013.

. 2013 Aug 20;31(24):3045-6.

doi: 10.1200/JCO.2013.49.1811. Epub 2013 Jul 8.

No abstract available

Comment in

Reply to P. Borchmann et al.
Longo DL. Longo DL. J Clin Oncol. 2013 Aug 20;31(24):3046. doi: 10.1200/JCO.2013.50.4316. Epub 2013 Jul 8. J Clin Oncol. 2013. PMID: 23943827 No abstract available.

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Gordon LI, Hong F, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Gospodarowicz M, Advani R, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ. Gordon LI, et al. J Clin Oncol. 2013 Feb 20;31(6):684-91. doi: 10.1200/JCO.2012.43.4803. Epub 2012 Nov 26. J Clin Oncol. 2013. PMID: 23182987 Free PMC article. Clinical Trial.
Treatment of advanced Hodgkin lymphoma: the more things change, the more they stay the same.
Longo DL. Longo DL. J Clin Oncol. 2013 Feb 20;31(6):660-2. doi: 10.1200/JCO.2012.44.7235. Epub 2012 Nov 26. J Clin Oncol. 2013. PMID: 23182992 No abstract available.